Business Context and Reporting Period
Company: Envoy Medical, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: December 16, 2025
Reporting Period: Event-based (December 16, 2025)
Business Context: The Company is an emerging growth company incorporated in Delaware. This filing serves to disclose an updated Investor Presentation intended for use in meetings with current and potential investors.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of an attached presentation rather than a financial statement.
Material Changes
No material changes to financial results or operations are detailed within the text of this Form 8-K. The primary event is the furnishing of an updated Investor Presentation (Exhibit 99.1).
Guidance, Outlook, and Risks
- Management Commentary: The attached Investor Presentation contains forward-looking statements regarding the Company's outlook.
- Risks and Contingencies: The filing explicitly references a discussion of risks and uncertainties related to forward-looking statements on Page 2 of the attached Investor Presentation.
- Legal Status: The information in this Item 7.01, including the Investor Presentation, is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Investor Presentation) for specific financial projections, operational updates, and detailed risk factors.
- Verify the forward-looking statements and associated risk disclosures on Page 2 of the Investor Presentation.
- Confirm the trading status of Class A Common Stock (Symbol: COCH) and Redeemable Warrants (Symbol: COCHW) on The Nasdaq Stock Market LLC.
- Note that the Company is classified as an emerging growth company.